Investigation Overview
July 28, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Thoratec Corporation (NASDAQ:THOR), was announced concerning whether the takeover of Thoratec Corporation by St. Jude Medical for $63.50 per share is unfair to NASDAQ:THOR stockholders. The investigation by a law firm concerns whether certain officers and directors of Thora...
You must register (for free) or login to view the entire investigation.